if a takeover does eventuate then I would be happy either way because TRPC 6 inhibitor giving positive results in humans is worth billions. But still think they should license each indication it’s more profitable for the company in the long run.
- Forums
- ASX - By Stock
- NYR
- CHART
NYR
nyrada inc.
Add to My Watchlist
10.2%
!
54.0¢
CHART, page-30
-
-
Top Stories
- There are more pages in this discussion • 1,414 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.